Disease Heterogeneity in Na+/Citrate Cotransporter Deficiency
Irina Anselm1, Morgan MacCuaig2, Sanjay B Prabhu3
1Department of Neurology, Harvard Medical School, Boston Children's Hospital, 300 Longwood Avenue, Fegan 11, Boston, MA, 02115, USA. Irina.Anselm@childrens.harvard.edu.
Abstract:
We report a novel mutation found in two siblings, a male and a female aged 8 and 5 years, respectively. Both patients presented with developmental delay and intractable seizures consistent with previous reports of SLC13A5 transporter deficiency. Both had two mutations in the SLC13A5 gene, c.655G>A (G219R) and the novel mutation c.245A>G (Y82C). However, the phenotypes were not identical as the female had focal cortical dysplasia that led to brain surgery. This is another example of the heterogeneity in disease expression even when the genotype is identical in the affected individuals.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transcellular Transport of Solutes
Secondary Active Transport
Secondary Active Transport


